This will be a great program for those of you in the Boston/Cambridge area on October 4th. HL7 experts will be describing the 5 HL7 Standards selected for meaningful use. I'll be speaking on CCD and CDA as you see below, and we've lined up experts and excellent speakers on the other HL7 standards.
Health Level Seven® International
For Immediate Release
HL7 to Offer Program on Standards for Meaningful Use of EHR Technology at Annual Plenary and Working Group Meeting
Ann Arbor, Michigan, USA – August 26, 2010 – Health Level Seven® International (HL7®), the global authority for interoperability and standards in healthcare information technology, today announced the speakers for their Ambassador program on Standards for Meaningful Use being held Monday, October 4, 2010 in Cambridge, MA. This program qualifies for three Continuing Medical Education credits (CME) approved through the American College of Physicians and provides an overview of the HL7 standards used to achieve meaningful use under the new federal regulations.
“As the healthcare industry is pushed forward to meet the meaningful use requirements under the ARRA-HITECH act, healthcare IT professionals and healthcare providers will have to work together to integrate computer systems and share patient data,” said Grant M. Wood, Senior IT Strategist at Intermountain Healthcare’s Clinical Genetics Institute in Salt Lake City, and host of the program. “HL7 has solutions – from sharing lab data, to sharing summary data about a patient as they move from doctor to doctor, to even those who provide public health services like disease surveillance and immunization registries. This multi-topic session will help budding experts achieve this goal.”
The program includes:
- HL7 and Meaningful Use by Gora Datta, Chairman and CEO, CAL2CAL Corporation. Mr. Datta will provide an overview of what meaningful use requires, and how HL7 has been involved in the development of standards for meaningful use.
- HL7 Version 2 and Immunization by Alean Kirnak, President, Software Partners LLC; American Immunization Registry Association; Co-Chair, HL7 Public Health and Emergency Response Work Group. Ms. Kirnak will describe the approaches to meeting Meaningful Use immunization registry reporting criteria using HL7 Version 2. She will discuss the place of immunization registry reporting within the overall context of the meaningful use rule, as well as the potential future benefits to providers.
- HL7 Version 2 and Surveillance by Lori Reed-Fourquet, Consultant, eHealthSign, LLC and Anna Orlova, PhD, Executive Director, Public Health Data Standards Consortium Ms. Reed-Fourquet and Dr. Orlova will describe standards and approaches for meeting meaningful use requirements involving public health surveillance. They will discuss both provider and public health perspectives for bi-directional interoperable communications using multiple HL7-based messages, documents, and services.
- HL7 Version 2 and Electronic Lab Reporting by Austin Kreisler, Technical Fellow, SAIC; Co-Chair, HL7 Orders & Observations Work Group; Co-Chair, HL7 Domain Experts Steering Division; Member, HL7 Technical Steering Committee. Mr. Kreisler will describe the relationship between meaningful use and the reporting of laboratory result data to public health agencies. This presentation will describe the various ways laboratory result data are utilized by public health agencies and show how HL7 standards are used to facilitate use of that laboratory data.
- HL7’s CDA and CCD Standards by Keith W. Boone, Standards Architect, GE Healthcare; Co-Chair, HL7 Clinical Document Architecture Work Group; Co-Chair, IHE Patient Care Coordination; past Co-Chair, ANSI/HITSP Care Management and Health Records. Mr. Boone will describe the use of the HL7 CDA standard and CCD implementation guide to create clinical summaries and exchange health information between eligible providers and hospitals. This session will also address the use of the HITSP C32 specification to the HL7 standards and guides.
The Ambassador Program event on HL7 and the final rule on standards for meaningful use will be held Monday afternoon immediately following the plenary meeting. For more information about this session, please visit http://www.hl7.org/events/boston102010/ambassador.asp. Additional tutorials providing more detail on HL7 standards for meaningful use, including HL7 Version 2, CDA Release 2 and CCD, are offered throughout the week. For more information about HL7 tutorials, please visit http://www.hl7.org/events/boston102010/tutorials.asp.
Online registration is now open. Early bird registration offers a discounted rate through September 10, 2010. To register online, visit http://www.hl7.org/events/boston102010/. Advance registrations will be accepted until September 24, 2010. After September 24, 2010, registrations must be made on-site in Cambridge, MA.
HL7 Working Group meetings are held three times a year to provide its more than 40 work groups a chance to meet together to work on the standards and provide educational sessions for the healthcare IT community.
About Health Level Seven International (HL7)
Founded in 1987, Health Level Seven International is the global authority for healthcare Information interoperability and standards with affiliates established in more than 30 countries. HL7 is a non-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7’s more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7 collaborates with other standards developers and provider, payer, philanthropic and government agencies at the highest levels to ensure the development of comprehensive and reliable standards and successful interoperability efforts.
HL7’s endeavors are sponsored, in part, by the support of its benefactors: Abbott; Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Epic Systems Corporation; European Medicines Agency; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technology; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis Pharmaceuticals Corporation; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; Quest Diagnostics Inc.; Siemens Healthcare; St. Jude Medical; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.
Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Croatia, Czech Republic, Finland, Germany, Greece, Hong Kong, India, Italy, Japan, Korea, The Netherlands, New Zealand, Norway, Romania, Russia, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, and Uruguay.
For more information, please visit: http://www.hl7.org/
# # #